Hypertrophic cardiomyopathy with coronary artery disease: Difference between revisions
Line 9: | Line 9: | ||
====[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]]==== | ====[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]]==== | ||
'''1.''' Coronary arteriography (invasive or computed tomographic imaging) is indicated in patients with HCM with chest discomfort who have an intermediate to high likelihood of CAD when the identification of concomitant CAD will change management strategies. | |||
====[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class III]] (Harm)==== | ====[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class III]] (Harm)==== |
Revision as of 20:37, 1 October 2012
Hypertrophic Cardiomyopathy Microchapters |
Differentiating Hypertrophic Cardiomyopathy from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Hypertrophic cardiomyopathy with coronary artery disease On the Web |
FDA on Hypertrophic cardiomyopathy with coronary artery disease |
CDC on Hypertrophic cardiomyopathy with coronary artery disease |
Hypertrophic cardiomyopathy with coronary artery disease in the news |
Blogs on Hypertrophic cardiomyopathy with coronary artery disease |
Directions to Hospitals Treating Hypertrophic cardiomyopathy |
Risk calculators and risk factors for Hypertrophic cardiomyopathy with coronary artery disease |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Concomitant Coronary Disease
2011 ACCF/AHA Guideline Recommendations: Detection of Concomitant Coronary Disease(DO NOT EDIT)
“ |
Class I1. Coronary arteriography (invasive or computed tomographic imaging) is indicated in patients with HCM with chest discomfort who have an intermediate to high likelihood of CAD when the identification of concomitant CAD will change management strategies. Class III (Harm)Class IIa |
” |